CryoPort (NASDAQ:CYRX) Insider Edward Zecchini Sells 1,400 Shares

CryoPort, Inc. (NASDAQ:CYRX) insider Edward Zecchini sold 1,400 shares of the business’s stock in a transaction on Wednesday, June 10th. The shares were sold at an average price of $15.23, for a total transaction of $21,322.00. Following the sale, the insider directly owned 109,719 shares of the company’s stock, valued at $1,671,020.37. This represents a 1.26% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

CryoPort Price Performance

NASDAQ CYRX traded up $0.24 during mid-day trading on Friday, hitting $14.62. The company’s stock had a trading volume of 502,102 shares, compared to its average volume of 554,117. CryoPort, Inc. has a 52-week low of $6.16 and a 52-week high of $16.73. The stock’s fifty day simple moving average is $12.30 and its two-hundred day simple moving average is $10.30. The firm has a market capitalization of $736.85 million, a P/E ratio of 10.83 and a beta of 1.90.

CryoPort (NASDAQ:CYRX) last announced its quarterly earnings results on Monday, May 4th. The company reported ($0.23) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.03). CryoPort had a negative return on equity of 7.92% and a net margin of 41.57%.The business had revenue of $47.80 million for the quarter, compared to analysts’ expectations of $44.86 million. On average, equities analysts forecast that CryoPort, Inc. will post -0.85 earnings per share for the current fiscal year.

Institutional Investors Weigh In On CryoPort

Institutional investors and hedge funds have recently bought and sold shares of the business. Basepoint Wealth LLC acquired a new stake in CryoPort during the fourth quarter worth about $34,000. Tower Research Capital LLC TRC increased its stake in shares of CryoPort by 300.1% in the second quarter. Tower Research Capital LLC TRC now owns 5,833 shares of the company’s stock valued at $44,000 after purchasing an additional 4,375 shares during the period. AlphaQuest LLC acquired a new stake in shares of CryoPort in the third quarter valued at approximately $79,000. Quadrature Capital Ltd acquired a new stake in shares of CryoPort in the fourth quarter valued at approximately $97,000. Finally, Corient Private Wealth LLC acquired a new stake in shares of CryoPort in the fourth quarter valued at approximately $113,000. Institutional investors and hedge funds own 92.90% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently commented on CYRX shares. Guggenheim increased their price target on shares of CryoPort from $11.00 to $12.00 and gave the stock a “buy” rating in a research report on Tuesday, May 5th. Needham & Company LLC increased their price target on shares of CryoPort from $13.00 to $15.00 and gave the stock a “buy” rating in a research report on Tuesday, May 5th. Weiss Ratings upgraded shares of CryoPort from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, May 6th. Jefferies Financial Group set a $13.50 price objective on shares of CryoPort in a research note on Monday. Finally, BTIG Research increased their price objective on shares of CryoPort from $15.00 to $17.00 and gave the stock a “buy” rating in a research note on Tuesday, May 5th. Eight research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $15.11.

CryoPort Company Profile

CryoPort, Inc (NASDAQ: CYRX) is a global provider of temperature-controlled logistics solutions for the life sciences industry. The company specializes in cryogenic shipping for critical biological materials, supporting the development, clinical testing and commercialization of cell and gene therapies, biologics, vaccines and reproductive medicine. By offering end-to-end supply chain management, CryoPort helps ensure the integrity and viability of temperature-sensitive products from point of origin to destination.

CryoPort’s product portfolio includes proprietary cryogenic dry shippers, advanced active and passive thermal packaging, and real-time data monitoring platforms.